Purchases and Sales Made in Q1 2024 in Intra Cellular Therapies, Inc. (ITCI)
This table provides information about the institutional ownership of Intra Cellular Therapies, Inc. (ITCI) during Q1 2024. The information is specifically focused on institutions that hold shares of Intra-Cellular Therapies, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-247K- 8.05% |
$15.9M - $18.7M
|
2.82M
$372M
|
|
|
Oct 07, 2024
Q1 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-300K- 38.85% |
$19.3M - $22.7M
|
473K
$62.3M
|
|
|
May 09, 2024
Q1 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-300K- 38.85% |
$19.3M - $22.7M
|
473K
$62.3M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-302K- 24.33% |
$19.5M - $22.9M
|
940K
$124M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-302K- 24.33% |
$19.5M - $22.9M
|
940K
$124M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-317K- 15.28% |
$20.4M - $24M
|
1.76M
$232M
|
|
|
May 15, 2024
Q1 2024
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-353K- 27.96% |
$22.7M - $26.7M
|
909K
$120M
|
|
|
May 15, 2024
Q1 2024
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-500K- 25.0% |
$32.2M - $37.8M
|
1.5M
$198M
|
|
|
May 14, 2024
Q1 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-514K- 38.53% |
$33.1M - $38.9M
|
821K
$108M
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-3.53M- 66.78% |
$227M - $267M
|
1.76M
$232M
|